Amplification of pfmdr1 , pfcrt , pvmdr1 , and K13 Propeller Polymorphisms Associated with Plasmodium falciparum and Plasmodium vivax Isolates from the China-Myanmar Border
Open Access
- 1 May 2015
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 59 (5), 2554-2559
- https://doi.org/10.1128/aac.04843-14
Abstract
Malaria in the China-Myanmar border region is still severe; local transmission of both falciparum and vivax malaria persists, and there is a risk of geographically expanding antimalarial resistance. In this research, the pfmdr1 , pfcrt , pvmdr1 , and K13-propeller genotypes were determined in 26 Plasmodium falciparum and 64 Plasmodium vivax isolates from Yingjiang county of Yunnan province. The pfmdr1 (11.5%), pfcrt (34.6%), and pvmdr1 (3.1%) mutations were prevalent at the China-Myanmar border. The indigenous samples exhibited prevalences of 14.3%, 28.6%, and 14.3% for pfmdr1 N86Y, pfcrt K76T, and pfcrt M74I, respectively, whereas the samples from Myanmar showed prevalences of 10.5%, 21.1%, and 5.3%, respectively. The most prevalent genotypes of pfmdr1 and pfcrt were Y 86 Y 184 and M 74 N 75 T 76 , respectively. No pvmdr1 mutation occurred in the indigenous samples but was observed in two cases coming from Myanmar. In addition, we are the first to report on 10 patients (38.5%) with five different K13 point mutations. The F446I allele is predominant (19.2%), and its prevalence was 28.6% in the indigenous samples of Yingjiang county and 15.8% in samples from Myanmar. The present data might be helpful for enrichment of the molecular surveillance of antimalarial resistance and useful for developing and updating guidance for the use of antimalarials in this region.Keywords
This publication has 37 references indexed in Scilit:
- Gene Amplification of the Multidrug Resistance 1 Gene of Plasmodium vivax Isolates from Thailand, Laos, and MyanmarAntimicrobial Agents and Chemotherapy, 2008
- Declining Artesunate-Mefloquine Efficacy against Falciparum Malaria on the Cambodia–Thailand BorderEmerging Infectious Diseases, 2008
- Plasmodium vivax resistance to chloroquine in Dawei, southern MyanmarTropical Medicine & International Health, 2008
- Decreasingpfmdr1Copy Number inPlasmodium falciparumMalaria Heightens Susceptibility to Mefloquine, Lumefantrine, Halofantrine, Quinine, and ArtemisininThe Journal of Infectious Diseases, 2006
- Identification of thePlasmodium vivax mdr‐Like Gene(pvmdr1)and Analysis of Single‐Nucleotide Polymorphisms among Isolates from Different Areas of EndemicityThe Journal of Infectious Diseases, 2005
- The origins of antimalarial drug resistanceTrends in Parasitology, 2004
- Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North MyanmarTropical Medicine & International Health, 2004
- Intercontinental Spread of Pyrimethamine-Resistant MalariaScience, 2004
- Changes in susceptibility of Plasmodium falciparum to artesunate in vitro in Yunnan Province, ChinaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2003
- Clinical trials of artemisinin and its derivatives in the treatment of malaria in ChinaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1994